nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think?
|
Yılmaz, Umut |
|
|
12 |
1 |
p. 157-161 |
artikel |
2 |
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?
|
Agostinetto, Elisa |
|
|
12 |
1 |
p. 19-29 |
artikel |
3 |
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario
|
Di Lorenzo, Giuseppe |
|
|
12 |
1 |
p. 147-155 |
artikel |
4 |
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
|
Metro, Giulio |
|
|
12 |
1 |
p. 173-174 |
artikel |
5 |
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
|
Habr, Dany |
|
|
12 |
1 |
p. 115-129 |
artikel |
6 |
Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK
|
Frank, Pauline |
|
|
12 |
1 |
p. 97-114 |
artikel |
7 |
From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa
|
Dlamini, Zodwa |
|
|
12 |
1 |
p. 1-11 |
artikel |
8 |
Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies
|
diZerega, Gere S. |
|
|
12 |
1 |
p. 31-55 |
artikel |
9 |
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
|
Ko, Heidi |
|
|
12 |
1 |
p. 13-17 |
artikel |
10 |
Long Term Remission of Capillary Leak Syndrome Associated with Monoclonal Gammopathy with Progression to Multiple Myeloma After Autologous Stem Cell Transplantation: a Case Report and Review of the Literature
|
Hermida, Gerardo |
|
|
12 |
1 |
p. 183-188 |
artikel |
11 |
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab
|
Bernabé, Reyes |
|
|
12 |
1 |
p. 175-182 |
artikel |
12 |
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
|
Pepe, Francesco |
|
|
12 |
1 |
p. 73-95 |
artikel |
13 |
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors
|
Chen, Hong |
|
|
12 |
1 |
p. 131-145 |
artikel |
14 |
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
|
Metro, Giulio |
|
|
12 |
1 |
p. 163-171 |
artikel |
15 |
Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation
|
Thomas, Xavier |
|
|
12 |
1 |
p. 57-72 |
artikel |